LONDON, May 26, 2016 /PRNewswire/ -- The generic injectable drug segment is a rapidly evolving and highly competitive market that lacks a true data compass to assist decision makers in mapping strategies for success in this segment. Attempting to determine the optimal time to file an ANDA application is a process that can be worth significant profits for first-to-filers. But it is a process that is marked by little in the way of analytical decision support and in which litigation has become a staple defensive mechanism for both the filer and the branded drug owner. There are 235 distinct APIs for which there is at least one approved generic injectable ANDA. These 235 APIs account for 1,167 approved ANDAs. Including all approved doses, the current universe of generic injectables consists of 1,699 unique injectable products. These products are currently marketed and supplied by slightly less than one hundred companies. Competition among the various drug and therapeutic classes is uneven, with the top ten segments accounting for a disproportionate level of activity and revenue. Understanding the underlying factors affecting business performance is key to attaining financial targets.
Generic Injectables – What You Will Learn
- Provides detailed analysis of generic drugs supplied as injectables and assesses key market segments, market dynamics and potential product opportunities
- Presents the competitive picture for generic injectables in two dozen drug classes
- Evaluates the importance of ANDA filing strategies and indirect ANDA acquisition on participant growth prospects
- Analyzes the impact of patents, exclusivity and litigation on participant market sector prospects
- Assesses the market presence and product position of the top twenty-four generic injectables suppliers
- Evaluates the impact of economic, technology, and regulatory factors
Download the full report: https://www.reportbuyer.com/product/3858945/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information: Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article